Population Health Sciences

A team led by researchers at Weill Cornell Medicine has used an AI-based approach to uncover underlying patterns among the conditions in which people are born, grow, live, work, and age, termed social determinants of health (SDoH), and then linked each pattern to children’s health outcomes.

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus. 

During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units (ICU) while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.” The hospitals most likely to be overloaded in imbalanced regions served a higher number of Black patients and more patients enrolled in Medicaid, according to a new study conducted by Weill Cornell Medicine investigators.

Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43 percent, from 5.3 percent to 7.6 percent a year.

State laws allowing medical cannabis use did not reduce prescriptions for opioids or other therapies for chronic, non-cancer pain, according to a policy analysis by Weill Cornell Medicine investigators.

The $9.8 million, five-year grant awarded to Weill Cornell Medicine and Columbia University will help combat cancer disparities fueled by persistent poverty.

A model for optimizing the dispensing of vaccines during pandemics that uses a new measure of success for such efforts has been developed by researchers at Weill Cornell Medicine, the Ithaca campus of Cornell University, Singapore University of Technology and Design and San Jose State University in California.

Hospitals participating in the 340B Drug Pricing Program, a large federal safety-net program, are financially incentivized to prescribe original biologic drugs to prevent and treat diseases in lieu of cheaper generic-like alternatives called biosimilar medications, according to a new study by Weill Cornell Medicine, NYU Grossman School of Medicine and University of Miami investigators.

While the peak of the COVID-19 pandemic seems to have passed, the effects of post-COVID conditions on public health remain. A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment. 

Financial disruption as a result of pandemic containment policies in the United States adversely influenced children’s mental health.

Weaknesses in the United States laboratory system, which were illuminated during the COVID-19 pandemic, underscore a need for policy changes to improve the country’s infectious disease response.

Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis.

The post-COVID syndrome known as long COVID has four major subtypes defined by different clusters of symptoms.

Individuals who were already pregnant at the beginning of the COVID-19 pandemic had a 50 percent lower exposure to...

A Medicare system that is meant to assess and incentivize healthcare quality with pay adjustments may not be working as intended, according to a study from researchers at Weill Cornell Medicine.

The Medicaid program allocates nearly $20 billion a year in subsidies to support safety-net hospitals and other health care providers that serve low-income patients. 

Weill Cornell Medicine has been awarded a five-year, $8.1 million grant from the National Institutes of Health (NIH) to support economic analysis, simulation modeling and other research approaches to help stem the national opioid epidemic. 

Dr. Jay Varma, a professor of population health sciences at Weill Cornell Medicine, has received a six-month, $1 million grant from the Bill & Melinda Gates Foundation to assess how countries around the world have been monitoring and reporting COVID-19 infections and outcomes during the pandemic.

By linking a national vascular registry with medical data records in Medicare claims for patients who underwent endovascular abdominal aortic aneurysm repair, researchers were able to identify which devices posed the most risk for reintervention.

Six Weill Cornell Medicine postdoctoral associates, instructors and junior faculty seeking to pursue independent research careers have received 2022 JumpStart Career Development awards.